comparemela.com

Latest Breaking News On - Linkdoc technology ltd - Page 10 : comparemela.com

US IPO market a danger zone for Chinese cos after Beijing crackdown

US IPO market a danger zone for Chinese cos after Beijing crackdown
dealstreetasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dealstreetasia.com Daily Mail and Mail on Sunday newspapers.

Analysis-U S IPO market a danger zone for Chinese firms after Beijing crackdown

Analysis-U S IPO market a danger zone for Chinese firms after Beijing crackdown
reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.

LinkDoc IPO taps China s growing demand for quality medical services

LinkDoc IPO taps China s growing demand for quality medical services
dealstreetasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dealstreetasia.com Daily Mail and Mail on Sunday newspapers.

Alibaba Health-backed medical data company LinkDoc files for US IPO

Alibaba Health-backed medical data company LinkDoc files for US IPO Visual from Pixabay June 15, 2021 LinkDoc Technology Ltd, a medical data company backed by a subsidiary of Alibaba Health Information Technology Ltd, filed for an initial public offering in the United States on Monday. The Beijing-based company, which offers cancer-focused healthcare services, reported a 41% jump in revenue for the three months ended March 31, according to the filing. For the same period, net loss attributable to LinkDoc widened to 135.4 million renminbi ($21.17 million) from 61.6 million renminbi a year earlier. The company’s listing plans come despite the US introducing measures that could result in foreign companies being delisted from American stock exchanges within three years if they do not comply with the country’s auditing standards.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.